FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Activated Charcoal Oral Suspension
Status: Discontinuation
»Therapeutic Categories: Other

Expand all

Padagis US LLC (New 05/15/2026)

Company Contact Information:
866-634-9120

Presentation	Posting Date	Related Information
Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74)	05/15/2026	Discontinuation of the manufacture of the drug
Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76)	05/15/2026	Discontinuation of the manufacture of the drug
Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25)	05/15/2026	Discontinuation of the manufacture of the drug
Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74)	05/15/2026	Discontinuation of the manufacture of the drug
Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76)	05/15/2026	Discontinuation of the manufacture of the drug